These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 25240785)
21. Platelets promote coagulation factor XII-mediated proteolytic cascade systems in plasma. Johne J; Blume C; Benz PM; Pozgajová M; Ullrich M; Schuh K; Nieswandt B; Walter U; Renné T Biol Chem; 2006 Feb; 387(2):173-8. PubMed ID: 16497149 [TBL] [Abstract][Full Text] [Related]
22. Effect of heparin on the activation of factor XII and the contact system in plasma. Pixley RA; Cassello A; De La Cadena RA; Kaufman N; Colman RW Thromb Haemost; 1991 Nov; 66(5):540-7. PubMed ID: 1725067 [TBL] [Abstract][Full Text] [Related]
23. In vitro activation of the contact (Hageman factor) system of plasma by heparin and chondroitin sulfate E. Hojima Y; Cochrane CG; Wiggins RC; Austen KF; Stevens RL Blood; 1984 Jun; 63(6):1453-9. PubMed ID: 6202346 [TBL] [Abstract][Full Text] [Related]
24. Assembly of the human plasma kinin-forming cascade along the surface of vascular endothelial cells. Reddigari S; Silverberg M; Kaplan AP Int Arch Allergy Immunol; 1995; 107(1-3):93-4. PubMed ID: 7613224 [TBL] [Abstract][Full Text] [Related]
25. Factor XII as a Therapeutic Target in Thromboembolic and Inflammatory Diseases. Nickel KF; Long AT; Fuchs TA; Butler LM; Renné T Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):13-20. PubMed ID: 27834692 [TBL] [Abstract][Full Text] [Related]
26. Induction of vascular permeability enhancement by human tryptase: dependence on activation of prekallikrein and direct release of bradykinin from kininogens. Imamura T; Dubin A; Moore W; Tanaka R; Travis J Lab Invest; 1996 May; 74(5):861-70. PubMed ID: 8642782 [TBL] [Abstract][Full Text] [Related]
27. Anti-allergic action of anti-malarial drug artesunate in experimental mast cell-mediated anaphylactic models. Cheng C; Ng DS; Chan TK; Guan SP; Ho WE; Koh AH; Bian JS; Lau HY; Wong WS Allergy; 2013 Feb; 68(2):195-203. PubMed ID: 23253152 [TBL] [Abstract][Full Text] [Related]
28. Pathways for bradykinin formation and inflammatory disease. Kaplan AP; Joseph K; Silverberg M J Allergy Clin Immunol; 2002 Feb; 109(2):195-209. PubMed ID: 11842287 [TBL] [Abstract][Full Text] [Related]
29. Scrodentoid A Inhibits Mast Cell-Mediated Allergic Response by Blocking the Lyn-FcεRIβ Interaction. Qian F; Zhang L; Lu S; Mao G; Guo F; Liu P; Xu J; Li Y Front Immunol; 2019; 10():1103. PubMed ID: 31156646 [No Abstract] [Full Text] [Related]
30. An investigational RNAi therapeutic targeting Factor XII (ALN-F12) for the treatment of hereditary angioedema. Liu J; Qin J; Borodovsky A; Racie T; Castoreno A; Schlegel M; Maier MA; Zimmerman T; Fitzgerald K; Butler J; Akinc A RNA; 2019 Feb; 25(2):255-263. PubMed ID: 30463937 [TBL] [Abstract][Full Text] [Related]
31. Absence of platelet endothelial cell adhesion molecule-1 (CD31) leads to increased severity of local and systemic IgE-mediated anaphylaxis and modulation of mast cell activation. Wong MX; Roberts D; Bartley PA; Jackson DE J Immunol; 2002 Jun; 168(12):6455-62. PubMed ID: 12055265 [TBL] [Abstract][Full Text] [Related]
32. Loss of the activity of human coagulation factor XII by a chymotrypsin-like protease activated in rat mast cells during degranulation with compound 48/80. Majima M; Tani Y; Katori M Thromb Res; 1987 Jun; 46(6):855-67. PubMed ID: 3307014 [TBL] [Abstract][Full Text] [Related]
33. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor. Scott CF; Silver LD; Schapira M; Colman RW J Clin Invest; 1984 Apr; 73(4):954-62. PubMed ID: 6561202 [TBL] [Abstract][Full Text] [Related]
34. Kinins, airway obstruction, and anaphylaxis. Kaplan AP Chem Immunol Allergy; 2010; 95():67-84. PubMed ID: 20519882 [TBL] [Abstract][Full Text] [Related]
35. NecroX-5 suppresses IgE/Ag-stimulated anaphylaxis and mast cell activation by regulating the SHP-1-Syk signaling module. Li X; Kwon O; Kim DY; Taketomi Y; Murakami M; Chang HW Allergy; 2016 Feb; 71(2):198-209. PubMed ID: 26456627 [TBL] [Abstract][Full Text] [Related]
36. ERK1/2 antagonize AMPK-dependent regulation of FcεRI-mediated mast cell activation and anaphylaxis. Hwang SL; Lu Y; Li X; Kim YD; Cho YS; Jahng Y; Son JK; Lee YJ; Kang W; Taketomi Y; Murakami M; Moon TC; Chang HW J Allergy Clin Immunol; 2014 Sep; 134(3):714-721.e7. PubMed ID: 24948367 [TBL] [Abstract][Full Text] [Related]
37. Tissue-Specific Expression of the Low-Affinity IgG Receptor, FcγRIIb, on Human Mast Cells. Burton OT; Epp A; Fanny ME; Miller SJ; Stranks AJ; Teague JE; Clark RA; van de Rijn M; Oettgen HC Front Immunol; 2018; 9():1244. PubMed ID: 29928276 [TBL] [Abstract][Full Text] [Related]
38. The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia. In vivo use of a monoclonal anti-factor XII antibody to block contact activation in baboons. Pixley RA; De La Cadena R; Page JD; Kaufman N; Wyshock EG; Chang A; Taylor FB; Colman RW J Clin Invest; 1993 Jan; 91(1):61-8. PubMed ID: 7678610 [TBL] [Abstract][Full Text] [Related]
39. AMP-activated protein kinase negatively regulates FcεRI-mediated mast cell signaling and anaphylaxis in mice. Hwang SL; Li X; Lu Y; Jin Y; Jeong YT; Kim YD; Lee IK; Taketomi Y; Sato H; Cho YS; Murakami M; Chang HW J Allergy Clin Immunol; 2013 Sep; 132(3):729-736.e12. PubMed ID: 23587332 [TBL] [Abstract][Full Text] [Related]